BIOCHIMIE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2019-11-05 尔宁

投出去一周被拒了，也没给审稿意见，让转投其他杂志

170 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2019-07-03 待时飞

没有版面费jcmax 2019-04-20 00:00:00 发表:
请问有版面费吗

jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗

167 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2019-04-20 jcmax

请问有版面费吗tulip81 2017-11-08 发表::
研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表:
8.18投稿
9.17一审大修，提的问题很细，要仔细回答
10.18提交修改稿
11.1二审小修
11.6 accept

tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept

123 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2019-04-20 jcmax

请问这个期刊有版面费吗

186 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2018-08-05 昵称暂无

中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表:
8.18投稿
9.17一审大修，提的问题很细，要仔细回答
10.18提交修改稿
11.1二审小修
11.6 accept

tulip81 2017-11-08 14:06:00 发表: 8.18投稿
9.17一审大修，提的问题很细，要仔细回答
10.18提交修改稿
11.1二审小修
11.6 accept

322 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2017-11-08 tulip81

审稿速度:1.0 | 投稿命中率:50.0
经验分享：8.18投稿
9.17一审大修，提的问题很细，要仔细回答
10.18提交修改稿
11.1二审小修
11.6 accept

248 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2017-10-11 .。

请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?

296 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

305 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2015-09-17 xiaolinlhy

最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？

388 0

[GetPortalCommentsPageByObjectIdResponse(id=579388, encodeId=c0b45e938835, content=投出去一周被拒了，也没给审稿意见，让转投其他杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Tue Nov 05 15:55:00 CST 2019, time=2019-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573249, encodeId=7efa5e3249b6, content=没有版面费jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, beContent=jcmax 2019-04-20 00:00:00 发表: 请问有版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRh1fjic1OVWyQtickbIYT4gaVPibJibaIOM0nSQMDe3C8XHAJSva42cU5nYdaEx5qfoJfL1POtFVmeUl/0, createdBy=6dfb2087717, createdName=待时飞, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569770, encodeId=4e69569e70ed, content=请问有版面费吗tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accepttulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 发表:: 研究方向：中药毒理学;; 接收率：约50% 审稿时间：约1个月 SCI(2016)：3.112 SCI(2015)：2.474 SCI(2014)：2.963 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569769, encodeId=62cc569e69ed, content=请问这个期刊有版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b012111359, createdName=jcmax, createdTime=Sat Apr 20 00:00:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559859, encodeId=91da559859fb, content=中药单体药效的能投吗？tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=tulip81 2017-11-08 14:06:00 发表: 8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7162409744, createdName=昵称暂无, createdTime=Sun Aug 05 00:00:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549015, encodeId=afc1549015f0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8.18投稿 9.17一审大修，提的问题很细，要仔细回答 10.18提交修改稿 11.1二审小修 11.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=051a1615421, createdName=tulip81, createdTime=Wed Nov 08 14:06:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548129, encodeId=a4ad5481298a, content=请问大修后2个半月还没有动静，正常吗？催稿信应该发给谁？还是在杂志系统里send email?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43981982950, createdName=.。, createdTime=Wed Oct 11 10:58:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539322, encodeId=ebaa53932220, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515391, encodeId=af4851539153, content=最近投了一篇文章，两个星期过去了一点反应都没有，有投过稿的朋友共享经验么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43541613477, createdName=xiaolinlhy, createdTime=Thu Sep 17 10:54:00 CST 2015, time=2015-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515011, encodeId=7dbe51501175, content=投稿命中率:25.0 经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed Sep 02 12:21:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

2015-09-02 fuhongxue007

投稿命中率:25.0
经验分享：8月份提交稿号都600+了，去年收录278篇文章，看来中稿率也就25%

372 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务